Market View 17th Feb, 2025

View on market: Volatility Prevails, Market is searching for better value

Most Asia-Pacific markets traded higher after Japan’s GDP grew by 2.8% in the fourth quarter, surpassing expectations of a 1% increase. This strong economic performance boosted investor sentiment, with the Nikkei 225 and Kospi both seeing modest gains. In contrast, the Australian market, represented by the S&P ASX 200, declined slightly. In the United States, major stock indices closed mixed, with the Dow Jones and S&P 500 posting small losses, while the Nasdaq Composite rose by a slight margin. Meanwhile, Indian stock markets ended the day lower, continuing their longest losing streak in two years. The NSE Nifty 50 and BSE Sensex both closed down, reflecting ongoing market concerns. Despite Japan’s positive GDP growth, the global market environment remained mixed, with some regions seeing gains and others facing declines. Investor sentiment remained cautious as markets responded to varying economic indicators.

Key Today’s Q3 Results

ABB, MAHESH.

Economic Calendar:

• USD: NAHB Housing Market Index (Feb) on 18^th February 2025.
• IND: M3 Money Supply on 19^th February 2025.
• USD: Initial Jobless Claims on 20^th February 2025.
• IND: S&P Global Manufacturing and Services PMI on 21^st February 2025.

IPO Watch:

Brokerage Radar:

JEFFERIES ON SAMVARDHANA MOTHERSON:

Maintain Buy, target price at ₹165 (from 185), EBIDTA margins come above estimates, Global auto environment remains challenging, Co is expanding its exposure to non-auto segments such electronics and space pobo, Finding inorganic opportunities at attractive valuations, Cut FY25 EPS by 9%.

HSBC ON PHARMA:

Concerns on US tariffs appear overdone, Indian companies supply 60% of generic drug volume to US, They help US healthcare system to lower costs, 10% tariff would lead to 1-6.5% cut to FY26 EPS, Bear case-DRL, Lupin, Aurobindo, Cipla, Zydus to be impacted all, Sun Pharma and Torrent Pharma could see minimal impact due to low dependency on US sales.

JEFFERIES ON AMBER ENTERPRISES:

Maintain Buy, target price ₹8,845, Domestic AC industry could grow +30% YoY, Led by strong Q1 summer and channel filing in Q2,Q3, Electronics business-imposition of anti-dumping duty in PCBs led to new customers, Mobile growth impacted due to order delays, FY24-27 expect margin accretive components CAGR-35% to outpace AC-22%.

International Markets:

U.S & Europe:

*As per 17^thFebruary.

 Asian markets:

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs:

NEWS UPDATES

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214 

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

• all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
• No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

• EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
• EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. 2. Compensation

• EWL or its associates have not received any compensation from the subject company in the past twelve months;
• EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
• EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research

3. In respect of Public Appearances

• EWL or its associates have not received any compensation from the subject company in the past twelve months;
• The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL